PATENT CLAIM ANALYSIS

Application Number: 15977586
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "019500"]

Abstract:
The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.

Claim (Index 30):
A conjugate, or a pharmaceutically acceptable salt thereof, having a formula\n B-L-(D) n  or a pharmaceutically acceptable salt thereof;\n wherein B is a urea of lysine and glutamic acid; \n L is a polyvalent linker comprising a cyclic structure selected from the group consisting of a cyclic ether, a cyclic amine, a heterocycle, an arylene, and a heteroarylene; \n D is a therapeutic agent or a PET imaging agent; \n wherein n is 1; and \n wherein the conjugate is not of the formula

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.72727
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14443212', '15245505', '15959110', '12673931', '15606913']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6766496155788216
- 35 USC 102 Novelty (BERT): 0.5550063002049184
- Combined Prediction Score: 0.6644852840414314
- Mean Citation Score: 320.363966
- Max Citation Score: 416.83243
- Similarity Product: 303.3557651595694

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test